BML, Inc. operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML with three other
pharmaceutical manufacturers in Asia:
Falco Sd Holdings Company Limited
sales of 62.76 billion Japanese Yen [US$616.28 million]
of which 47%
was Medical Test),
Zhejiang DiAn Diagnostics Co Ltd
(1.02 billion Chinese Renmimbi [US$163.22 million]
Medical & Biological Laboratories Company Limited
(6.92 billion Japanese Yen [US$68.00 million]
of which 100%
was Reagent business).
BML reported sales of ¥94.61 billion (US$929.05 million)
March of 2013.
increase of 2.6%
versus 2012, when the company's sales were ¥92.20 billion.
Sales at BML have increased during each of the previous five years
(and since 2008, sales have increased a total of 30%).
Sales of Related Businesses saw an increase
that was more than double the company's growth rate: sales were up
8.2% in 2013, from
¥219.00 million to ¥237.00 million.
Not all segments of BML experienced an increase in sales in 2013:
sales of Medical Information fell 0.8% to ¥3.23 billion.
(However, this segment's sales were only a very small portion of the company's overall sales).